MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) announced today it is pleased to see the recent study data showing Medicare patients suffering from degenerative spondylolisthesis with spinal stenosis showed substantially greater improvement when treated surgically versus non-surgically. The results were part of the Spine Patient Outcomes Research Trial (SPORT), a study conducted at 11 sites across the U.S. and sponsored by the National Institutes of Health.
